UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018292
Receipt number R000020168
Scientific Title The efficacy and safety of Tadarafil for treatment of nocturia and sleep quality
Date of disclosure of the study information 2015/07/13
Last modified on 2020/07/16 09:55:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and safety of Tadarafil for treatment of nocturia and sleep quality

Acronym

The efficacy of Tadarafil for nocturia and sleep disturbance

Scientific Title

The efficacy and safety of Tadarafil for treatment of nocturia and sleep quality

Scientific Title:Acronym

The efficacy of Tadarafil for nocturia and sleep disturbance

Region

Japan


Condition

Condition

Disease with lower urinary tract symptom

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For evaluating the efficacy of Tadarafil to nocturia and sleep disturbance

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Improving of urinary symptom score and sleep quality after 12 weeks medication

Key secondary outcomes

IPSS, QOL, OABSS, athene sleeing score, diary of urination


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

5mg of Tadarafil is administered to the patients once a day for 12 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1.Patients with nocturia(OABSS Total Score 3 or more and Q2 2 or more )
2.Patients who are considered eligible for the study by the attending physician
3.Patients who can understand the contents of the questionnaire without the help of others, and who can answer on their own
4.Patients who voluntarily provide written consent to participate in the study

Key exclusion criteria

1.Patients with a history of hypersensitivity to components of this drug
2.Patients with a history of serious cardiovascular (It have been reported heart rate increases, and there is a risk that symptoms worse.
3.Patients with severe hypertension
4.Patients with severe liver dysfunction (Child-Pugh score 10 or more) [There is a possibility that the blood concentration is excessively increased.]
5.Patients treated with flecainide acetate or propafenone hydrochloride in administration
6.Patients with chronic bacterial prostatitis or activity of urinary tract infection
7.Patients who carried the radiation therapy to the pelvis
8.Patients who suspected of having prostate cancer by PSA or rectal examination
9.Patients with urethral stricture
10.Patients who are considered ineligible for the study by the attending physician

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Ryoichi
Middle name
Last name Shiroki

Organization

Fujita Health University

Division name

Medicine/Department of Urology

Zip code

4701-1192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, JAPAN

TEL

0562-93-9257

Email

rshiroki@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Hitomi
Middle name
Last name Sasaki

Organization

Fujita Health University

Division name

Medicine/Department of Urology

Zip code

4701192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, JAPAN

TEL

0562-93-9257

Homepage URL


Email

sasakih@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University

Address

Toyoake

Tel

0562939257

Email

sasakih@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 10 Month 29 Day

Date of IRB

2014 Year 11 Month 22 Day

Anticipated trial start date

2015 Year 03 Month 01 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 07 Month 13 Day

Last modified on

2020 Year 07 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020168


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name